Skip to main content
Premium Trial:

Request an Annual Quote

Promega Asks Court to Stop Benitec from Licensing RNAi Technology

NEW YORK, Nov. 11 (GenomeWeb News) - Promega has filed a motion with the US District Court of Delaware seeking an injunction to stop Benitec from granting further licenses to ddRNAi technology to which it claims exclusivity.

The motion is the latest move in row between the two companies over rights to the RNAi technology. In July, Benitec sued Promega, which had acquired the exclusive rights to use and sublicense the ddRNAi technology in areas outside human therapeutics in exchange for $350,000 and royalties.

The suit claims that Promega had failed to meet its payment requirements to Benitec, and therefore had forfeited its exclusive rights to the technology in lieu of a non-exclusive license to simply use the technology.

Promega's motion follows Benitec's announcment in October that it had granted Artemis Pharmaceuticals of Cologne, Germany, a non-exclusive commercial license to use Benitec's ddRNAi technology.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.